Default header image

Assessment of a Novel Urine Biomarker for Acute Kidney Injury in Cats


To assess the potential of a possible new marker of acute kidney injury in cats – including Oncology patients that develop kidney disease during the course of their disease.

Inclusion criteria:  

Cats with following conditions:

  • severe systemic disease (including cancer)
  • aminoglycoside & NSAID therapies
  • low urinary tract obstruction
  • prerenal azotemia
  • exacerbation of chronic renal disease
  • acute renal failure.

Samples required:  

  • urine sample (1-5 mL), collected either by voidance, cystocentesis or catheterization.

Client Compensation:              

  • New diagnostic AKI assay performed at no cost to owner   


  • Dr. Dorothee Bienzele (PI)


Dr. Dorothee Bienzle: 519-824-4120; ext.54351

Vicky Sabine (PhD), Clinical Research Coordinator

Funded by OVC Pet Trust.

<Back to Current Trials